Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

CAR T-cell therapy of solid tumors.

Yong CSM, Dardalhon V, Devaud C, Taylor N, Darcy PK, Kershaw MH.

Immunol Cell Biol. 2017 Apr;95(4):356-363. doi: 10.1038/icb.2016.128. Epub 2016 Dec 22. Review.

PMID:
28003642
2.

[Subacute anti-N-methyl-D-aspartate receptor encephalitis. A serie of 13 paediatric cases].

Erazo R, González J, Quintanilla C, Devaud C, Gayoso C, Toledo X, Rauch E, Riffo C, Alvarez C, Salazar M, Salvo D, Dalmau J, Carmona O.

Rev Chil Pediatr. 2016 Nov - Dec;87(6):487-493. doi: 10.1016/j.rchipe.2016.06.006. Epub 2016 Jul 29. Spanish.

3.

A role for multiple chimeric antigen receptor-expressing leukocytes in antigen-specific responses to cancer.

Yong CS, John LB, Devaud C, Prince MH, Johnstone RW, Trapani JA, Darcy PK, Kershaw MH.

Oncotarget. 2016 Jun 7;7(23):34582-98. doi: 10.18632/oncotarget.9149.

4.

Expression of a Chimeric Antigen Receptor in Multiple Leukocyte Lineages in Transgenic Mice.

Yong CS, Westwood JA, Schröder J, Papenfuss AT, von Scheidt B, Moeller M, Devaud C, Darcy PK, Kershaw MH.

PLoS One. 2015 Oct 27;10(10):e0140543. doi: 10.1371/journal.pone.0140543. eCollection 2015.

5.

Cross-talk between tumors can affect responses to therapy.

Devaud C, John LB, Westwood JA, Yong CS, Beavis PA, Schwendener RA, Darcy PK, Kershaw MH.

Oncoimmunology. 2015 Jun 17;4(7):e975572. eCollection 2015 Jul.

6.

Differential potency of regulatory T cell-mediated immunosuppression in kidney tumors compared to subcutaneous tumors.

Devaud C, Westwood JA, Teng MW, John LB, Yong CS, Duong CP, Smyth MJ, Darcy PK, Kershaw MH.

Oncoimmunology. 2014 Dec 21;3(11):e963395. eCollection 2014 Nov.

7.

Foxp3 expression in macrophages associated with RENCA tumors in mice.

Devaud C, Yong CS, John LB, Westwood JA, Duong CP, House CM, Denoyer D, Li J, Darcy PK, Kershaw MH.

PLoS One. 2014 Sep 29;9(9):e108670. doi: 10.1371/journal.pone.0108670. eCollection 2014.

8.

Foxp3 expression in T regulatory cells and other cell lineages.

Devaud C, Darcy PK, Kershaw MH.

Cancer Immunol Immunother. 2014 Sep;63(9):869-76. doi: 10.1007/s00262-014-1581-4. Epub 2014 Jul 26. Review.

PMID:
25063364
9.

Enhancing immunotherapy using chemotherapy and radiation to modify the tumor microenvironment.

Kershaw MH, Devaud C, John LB, Westwood JA, Darcy PK.

Oncoimmunology. 2013 Sep 1;2(9):e25962. Epub 2013 Aug 2. Review.

10.

Immune modulation of the tumor microenvironment for enhancing cancer immunotherapy.

Devaud C, John LB, Westwood JA, Darcy PK, Kershaw MH.

Oncoimmunology. 2013 Aug 1;2(8):e25961. Epub 2013 Aug 22. Review.

11.

Tissues in different anatomical sites can sculpt and vary the tumor microenvironment to affect responses to therapy.

Devaud C, Westwood JA, John LB, Flynn JK, Paquet-Fifield S, Duong CP, Yong CS, Pegram HJ, Stacker SA, Achen MG, Stewart TJ, Snyder LA, Teng MW, Smyth MJ, Darcy PK, Kershaw MH.

Mol Ther. 2014 Jan;22(1):18-27. doi: 10.1038/mt.2013.219. Epub 2013 Sep 19.

12.

Blockade of A2A receptors potently suppresses the metastasis of CD73+ tumors.

Beavis PA, Divisekera U, Paget C, Chow MT, John LB, Devaud C, Dwyer K, Stagg J, Smyth MJ, Darcy PK.

Proc Natl Acad Sci U S A. 2013 Sep 3;110(36):14711-6. doi: 10.1073/pnas.1308209110. Epub 2013 Aug 20.

13.

Anti-PD-1 antibody therapy potently enhances the eradication of established tumors by gene-modified T cells.

John LB, Devaud C, Duong CP, Yong CS, Beavis PA, Haynes NM, Chow MT, Smyth MJ, Kershaw MH, Darcy PK.

Clin Cancer Res. 2013 Oct 15;19(20):5636-46. doi: 10.1158/1078-0432.CCR-13-0458. Epub 2013 Jul 19.

14.

Chimeric antigen receptor-redirected T cells display multifunctional capacity and enhanced tumor-specific cytokine secretion upon secondary ligation of chimeric receptor.

Henderson MA, Yong CS, Duong CP, Davenport AJ, John LB, Devaud C, Neeson P, Westwood JA, Darcy PK, Kershaw MH.

Immunotherapy. 2013 Jun;5(6):577-90. doi: 10.2217/imt.13.37.

PMID:
23725282
15.

Engineering T cell function using chimeric antigen receptors identified using a DNA library approach.

Duong CP, Westwood JA, Yong CS, Murphy A, Devaud C, John LB, Darcy PK, Kershaw MH.

PLoS One. 2013 May 7;8(5):e63037. doi: 10.1371/journal.pone.0063037. Print 2013.

16.

Anti-metastatic potential of human Vδ1(+) γδ T cells in an orthotopic mouse xenograft model of colon carcinoma.

Devaud C, Rousseau B, Netzer S, Pitard V, Paroissin C, Khairallah C, Costet P, Moreau JF, Couillaud F, Dechanet-Merville J, Capone M.

Cancer Immunol Immunother. 2013 Jul;62(7):1199-210. doi: 10.1007/s00262-013-1402-1. Epub 2013 Apr 26.

PMID:
23619975
17.

Functional characterization of a chimeric soluble Fas ligand polymer with in vivo anti-tumor activity.

Daburon S, Devaud C, Costet P, Morello A, Garrigue-Antar L, Maillasson M, Hargous N, Lapaillerie D, Bonneu M, Dechanet-Merville J, Legembre P, Capone M, Moreau JF, Taupin JL.

PLoS One. 2013;8(1):e54000. doi: 10.1371/journal.pone.0054000. Epub 2013 Jan 9.

18.

Oncolytic virus and anti-4-1BB combination therapy elicits strong antitumor immunity against established cancer.

John LB, Howland LJ, Flynn JK, West AC, Devaud C, Duong CP, Stewart TJ, Westwood JA, Guo ZS, Bartlett DL, Smyth MJ, Kershaw MH, Darcy PK.

Cancer Res. 2012 Apr 1;72(7):1651-60. doi: 10.1158/0008-5472.CAN-11-2788. Epub 2012 Feb 7.

19.

Adoptive immunotherapy combined with intratumoral TLR agonist delivery eradicates established melanoma in mice.

Amos SM, Pegram HJ, Westwood JA, John LB, Devaud C, Clarke CJ, Restifo NP, Smyth MJ, Darcy PK, Kershaw MH.

Cancer Immunol Immunother. 2011 May;60(5):671-83. doi: 10.1007/s00262-011-0984-8. Epub 2011 Feb 16.

20.

Antitumor activity of gammadelta T cells reactive against cytomegalovirus-infected cells in a mouse xenograft tumor model.

Devaud C, Bilhere E, Loizon S, Pitard V, Behr C, Moreau JF, Dechanet-Merville J, Capone M.

Cancer Res. 2009 May 1;69(9):3971-8. doi: 10.1158/0008-5472.CAN-08-3037. Epub 2009 Apr 21.

21.

Effects of grapefruit juice on the pharmacokinetics of the enantiomers of methadone.

Benmebarek M, Devaud C, Gex-Fabry M, Powell Golay K, Brogli C, Baumann P, Gravier B, Eap CB.

Clin Pharmacol Ther. 2004 Jul;76(1):55-63.

PMID:
15229464
22.

[Alarm systems for use in the treatment of primary nocturnal enuresis].

Corbillon E, Poullié AI, Devaud C, Cecchin M, Cardoso R, Missour S, Aubert D, Schmitt M, Fischbach M, Raes A, Van de Walle J, Van Egroo A, Bouissou F, Cochat P, Desvignes V, Autret-Leca E, Chaix-Couturier C, Manificat S, Chassany O; ANAES.

Arch Pediatr. 2004 May;11(5):474-9. French. No abstract available.

PMID:
15135442
23.

Identification and characterization of a novel ABCA subfamily member, ABCA12, located in the lamellar ichthyosis region on 2q34.

Annilo T, Shulenin S, Chen ZQ, Arnould I, Prades C, Lemoine C, Maintoux-Larois C, Devaud C, Dean M, Denèfle P, Rosier M.

Cytogenet Genome Res. 2002;98(2-3):169-76.

PMID:
12697999
24.

The human ATP binding cassette gene ABCA13, located on chromosome 7p12.3, encodes a 5058 amino acid protein with an extracellular domain encoded in part by a 4.8-kb conserved exon.

Prades C, Arnould I, Annilo T, Shulenin S, Chen ZQ, Orosco L, Triunfol M, Devaud C, Maintoux-Larois C, Lafargue C, Lemoine C, Denèfle P, Rosier M, Dean M.

Cytogenet Genome Res. 2002;98(2-3):160-8.

PMID:
12697998
25.

Characterization of the ABCA transporter subfamily: identification of prokaryotic and eukaryotic members, phylogeny and topology.

Peelman F, Labeur C, Vanloo B, Roosbeek S, Devaud C, Duverger N, Denèfle P, Rosier M, Vandekerckhove J, Rosseneu M.

J Mol Biol. 2003 Jan 10;325(2):259-74.

PMID:
12488094
26.

Eating disorders among female adolescents in Switzerland: prevalence and associations with mental and behavioral disorders.

Devaud C, Jeannin A, Narring F, Ferron C, Michaud PA.

Int J Eat Disord. 1998 Sep;24(2):207-16.

PMID:
9697019
27.

A transcriptional Map of the FMF region.

Bernot A, Heilig R, Clepet C, Smaoui N, Da Silva C, Petit JL, Devaud C, Chiannilkulchai N, Fizames C, Samson D, Cruaud C, Caloustian C, Gyapay G, Delpech M, Weissenbach J.

Genomics. 1998 Jun 1;50(2):147-60.

PMID:
9653642
28.

Preferential localization of the limb-girdle muscular dystrophy type 2A gene in the proximal part of a 1-cM 15q15.1-q15.3 interval.

Allamand V, Broux O, Richard I, Fougerousse F, Chiannilkulchai N, Bourg N, Brenguier L, Devaud C, Pasturaud P, Pereira de Souza A, et al.

Am J Hum Genet. 1995 Jun;56(6):1417-30.

29.

Mutations in the proteolytic enzyme calpain 3 cause limb-girdle muscular dystrophy type 2A.

Richard I, Broux O, Allamand V, Fougerousse F, Chiannilkulchai N, Bourg N, Brenguier L, Devaud C, Pasturaud P, Roudaut C, et al.

Cell. 1995 Apr 7;81(1):27-40.

30.

[Anorexia and bulimia: increasing disorders? A review of the literature on the epidemiology of eating disorders].

Devaud C, Michaud PA, Narring F.

Rev Epidemiol Sante Publique. 1995;43(4):347-60. Review. French.

PMID:
7667541
31.

[Body image, nutritional behavior and dysfunction among Swiss adolescents: a national survey].

Devaud C, Michaud PA, Narring F.

Rev Med Suisse Romande. 1994 Nov;114(11):1009-15. French. No abstract available.

PMID:
7801022
32.

Regional localization of human chromosome 15 loci.

Richard I, Broux O, Chiannilkulchai N, Fougerousse F, Allamand V, Bourg N, Brenguier L, Devaud C, Pasturaud P, Roudaut C, et al.

Genomics. 1994 Oct;23(3):619-27.

PMID:
7851890
33.

Mapping of a chromosome 15 region involved in limb girdle muscular dystrophy.

Fougerousse F, Broux O, Richard I, Allamand V, de Souza AP, Bourg N, Brenguier L, Devaud C, Pasturaud P, Roudaut C, et al.

Hum Mol Genet. 1994 Feb;3(2):285-93.

PMID:
8004096
34.

The gene for creatine kinase, mitochondrial 2 (sarcomeric; CKMT2), maps to chromosome 5q13.3.

Richard I, Devaud C, Cherif D, Cohen D, Beckmann JS.

Genomics. 1993 Oct;18(1):134-6.

PMID:
8276398

Supplemental Content

Loading ...
Support Center